Scientist IIIChildren's Hospital of PhiladelphiaPhiladelphia, Pennsylvania, United States
PB0776 - Characterization of the effects of hydroxyurea and crizanlizumab on plasma immunothrombosis biomarkers in patients with sickle cell disease
Monday, June 26, 202318:30 – 19:30 ET
OC 66.4 - Platelet factor 4 (PF4) enhances bacterial uptake and clearance by the endothelium, contributing to improved outcomes in sepsis
Tuesday, June 27, 202315:30 – 15:45 ET
